New drug combo aims to boost IVF success for women with hormone deficiency
NCT ID NCT07340827
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tests a new combination of two hormones (follitropin alfa and lutropin alfa) against a standard treatment (hMG) for Japanese women with LH and FSH deficiency who are undergoing IVF. The goal is to see which treatment helps produce more eggs for retrieval. About 266 women will participate, and the study lasts up to 13 months for those who become pregnant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
follitropin alfa and lutropin alfa (a combination of two hormones to stimulate egg growth)
What this could lead to
If this works, it could offer a more effective fertility treatment option for Japanese women with hormone deficiencies who need IVF.
What could go wrong
This is a Phase 3 trial, but it is still experimental. The new drug may not work better than the existing treatment, and side effects like ovarian hyperstimulation are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hanabusa Women's Clinic Hanabusa Women's Central Fertility Clinic - Dept of Obstetrics/Gynecology
RECRUITINGKobe, Hyōgo, 650-0021, Japan
Contact Email: •••••@•••••
Contact
-
JA-Nagano Shinonoi General Hospital - Dept of Obstetrics/Gynecology
RECRUITINGNagano, Nagano, 388-8004, Japan
Contact Email: •••••@•••••
Contact
-
KASHIWAZAKI OB/GYN CLINIC - Dept of Obstetrics/Gynecology
RECRUITINGSaitama-shi, Saitama, 330-0855, Japan
Contact Email: •••••@•••••
Contact
-
Kameda IVF Clinic Makuhari - Dept of Obstetrics/Gynecology
RECRUITINGChiba, Chiba, 261-8501, Japan
Contact Email: •••••@•••••
Contact
-
Kamiya Ladies Clinic - Dept of Gynecology
RECRUITINGSapporo, Hokkaido, 060-0003, Japan
Contact Email: •••••@•••••
Contact
-
Ladies Clinic Cosmos - Dept of Infertility Treatment
RECRUITINGKochi, Kochi, 780-0072, Japan
Contact Email: •••••@•••••
Contact
-
Sankeikai IVF Osaka Clinic - Dept of Obstetrics/Gynecology
RECRUITINGHigashiosaka-shi, Osaka, 577-0012, Japan
Contact Email: •••••@•••••
Contact
-
Sophia Ladies Clinic - Dept of Obstetrics/Gynecology
RECRUITINGSagamihara-shi, Kanagawa, 252-0233, Japan
Contact Email: •••••@•••••
Contact
-
Sugiyama Clinic Marunouchi - Dept of Obstetrics/ Gynecology
RECRUITINGChiyoda-ku, Tokyo-To, 100-0005, Japan
Contact Email: •••••@•••••
Contact
-
University of Tokyo Hospital - Dept of Obstetrics
RECRUITINGBunkyō City, Tokyo-To, 113-8655, Japan
Contact Email: •••••@•••••
Contact
-
YOKOTA Maternity Hospital - Dept of Reproductive Medical Gynecology
RECRUITINGMaebashi, Gunma, 371-0031, Japan
Contact Email: •••••@•••••
Contact